Method and composition for inhibiting cellular irreversible changes due to stress
CA 2247461 A1 · Owner: Miller, Guy · Inventors: Nakamura, John; Miller, Guy; Lou, Lillian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Formulations of naturally occurring physiologically acceptable compounds and their derivatives are provided for treatment of cellular stress particularly , hypoxia. By administering the formulations comprising for the most part , purines sugars, amino acids and physiologically acceptable derivatives thereof, by themselves or in combination with each other and with other compounds, particularly electron acceptor compounds the time to irreversible , cellular changes particularly mortality, can be greatly extended.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 20, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 20, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 20, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.